Literature DB >> 16763092

Phospholipase C-beta3 and -beta1 form homodimers, but not heterodimers, through catalytic and carboxyl-terminal domains.

Yong Zhang1, Walter K Vogel, Jennifer S McCullar, Jeffrey A Greenwood, Theresa M Filtz.   

Abstract

Phospholipase C-beta (PLC-beta) isoenzymes are key effectors in G protein-coupled signaling pathways. Prior research suggests that some isoforms of PLC-beta may exist and function as dimers. Using coimmunoprecipitation assays of differentially tagged PLC-beta constructs and size-exclusion chromatography of native PLC-beta, we observed homodimerization of PLC-beta3 and PLC-beta1 isoenzymes but failed to detect heterodimerization of these isoenzymes. Size-exclusion chromatography data suggest that PLC-beta3 and PLC-beta1 form higher affinity homodimers than PLC-beta2. Evidence supportive of limited PLC-beta monomer-homodimer equilibrium appears at < or =100 nM. Further assessment of homodimerization status by coimmunoprecipitation assays with differentially tagged PLC-beta3 fragments demonstrated that at least two subdomains of PLC-beta3 are involved in dimer formation, one in the catalytic X and Y domains and the other in the G protein-regulated carboxyl-terminal domain. In addition, we provide evidence consistent with the existence of PLC-beta homodimers in a whole-cell context, using fluorescent protein-tagged constructs and microscopic fluorescence resonance energy transfer assays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763092     DOI: 10.1124/mol.105.021923

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

Review 1.  Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding--how many ways can you activate an enzyme?

Authors:  Guillaume Drin; Suzanne Scarlata
Journal:  Cell Signal       Date:  2007-04-29       Impact factor: 4.315

2.  N-methyl-D-aspartate receptor subunits are non-myosin targets of myosin regulatory light chain.

Authors:  Gaurav Bajaj; Yong Zhang; Michael I Schimerlik; Andrew M Hau; Jing Yang; Theresa M Filtz; Chrissa Kioussi; Jane E Ishmael
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

Review 3.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

4.  CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth.

Authors:  Shuo Wang; Yanning Wu; Yuning Hou; Xiaoqing Guan; Marcello P Castelvetere; Jacob J Oblak; Sanjeev Banerjee; Theresa M Filtz; Fazlul H Sarkar; Xuequn Chen; Bhanu P Jena; Chunying Li
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

5.  PI(3,4,5)P3 potentiates phospholipase C-beta activity.

Authors:  Yong Zhang; Sun Hyung Kwon; Walter K Vogel; Theresa M Filtz
Journal:  J Recept Signal Transduct Res       Date:  2009       Impact factor: 2.092

6.  Phosphatidic acid is required for the constitutive ruffling and macropinocytosis of phagocytes.

Authors:  Michal Bohdanowicz; Daniel Schlam; Martin Hermansson; David Rizzuti; Gregory D Fairn; Takehiko Ueyama; Pentti Somerharju; Guangwei Du; Sergio Grinstein
Journal:  Mol Biol Cell       Date:  2013-04-10       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.